Cencora (STU:ABG) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


STU:ABG Cencora Inc STU:ABG
68 GF Score
Price €251.20
GF Value €257.78
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Cencora's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

STU:ABG vs CAH, MCK, HSIC: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Distribution subindustry, Cencora's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cencora Margin of Safety % (DCF Earnings Based) vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Cencora's Margin of Safety % (DCF Earnings Based) falls into.


STU:ABG
68GF Score
Cencora Inc STU:ABG
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cencora (STU:ABG) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be undervalued. The current stock price of €251.20 is trading 2.6% below its estimated GF Value™ of €257.78. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for STU:ABG:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €257.78 vs. price of €251.20 (2.6% below fair value)
  • GF Score™: 68/100 with 1 warning sign

No single metric tells the full story. See the STU:ABG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
68GF Score

Get the complete analysis for STU:ABG

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€251.20
Price
€257.78
GF Value